97 Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts  by Spellberg, B. et al.
Infections in Cancer and HematoLogicaL MaLignancies $55 
97 
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A.S. Ibrahim. Los AnBeles Biomedical Research 
Institute and the Division o[ Infectious Diseases at 
Harbor-UCLA Medical Center, Torrance, CA, USA 
Background: ALthough granuLocyte transfusion is 
a Logical therapeutic option for neutropenic pa- 
tients with refractory infections, significant tech- 
nical barriers have prevented its wide-spread use. 
Objectives: A novel phagocyte transfusion strat- 
egy has been developed based on activa- 
tion/differentiation of a human myeLoid ceLL Line, 
HU60. 
Methods: To optimize the HU60 transfusion sys- 
tem, varying durations of ceLL activation were com- 
pared, facile quality control markers were deveL- 
oped to track Lot-to-Lot variability, and the impact 
of Low close irradiation on ceLL function was deter- 
mined. 
Results: A three day period of activation resulted 
in increased ceLL viability and in vitro candidacidaL 
capacity, but with sLightLy higher ceLL replication, 
compared to a seven day activation period. CeLL 
viability and several facile flow cytometric mea- 
surements were accurate quaLity-controL markers 
for HL-60 activation. In combination with acti- 
vation, Low-dose irradiation abrogated replication 
while sparing the HL-60 ceLLs' candidacidaL effects. 
Infusion of irradiated, activated HL-60 ceLLs sig- 
nificantly improved survival of neutropenic, candi- 
demic mice. 
Conclusions: In summary, activated, irradiated HL- 
60 ceLLs are microbicidaL, have virtuaLLy no replica- 
tive capacity, and are safe and effective at protect- 
ing neutropenic mice against an otherwise 100% fa- 
tal candidaL infection. With continued deveLop- 
ment, this strategy to recapitulate neutrophiL func- 
tions has the potential to serve as an effective 
alternative to granuLocyte transfusions. 
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Analysis of the Role of [18F] Fluorodeoxyglucose 
(FDG) Positron Emission Tomography (PET) 
Imaging in Early Diagnosis and Management of 
Invasive Mold Infections (IMIs) 
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compromised patients. EarLy diagnosis of IMIs by 
conventional methods is chaLLenging, and there is 
need for innovation in this area. Emerging evi- 
dence suggests that [18F] fluorodeoxygLucose (FDG) 
positron emission tomography (PET) imaging could 
be a useful tool in diagnosis and management of 
a range of opportunistic infections in immunocom- 
promised patients. 
Methods: We retrospectively evaluated the medi- 
cal records of patients with probable or proven IMI 
(n= 13) who underwent FDG PET imaging around 
the time of their infection, at The University of 
Texas M.D. Anderson Cancer Center over a 5-year 
period (12/1999 to 4/2004). We additionaLLy re- 
viewed the avaiLabLe Literature on FDG PET imaging 
in diagnosis and/or foLLow up of patients with IMIs 
(n=9). 
Results: We identified 22 patients with IMIs (15 def- 
inite, 7 probable). FDG PET imaging was performed 
for cancer staging in the majority (14/22 or 64%) of 
cases. Most patients had an underling malignancy 
(16/22 or 73%), primarily of haematotogicat origin 
(12/16 or 75%), and typical risk factors for IMIs, 
including receipt of a significant dose of corticos- 
teroids (14/22 or 46%), and severe neutropenia 
(4/22 or 18%). In 7 recipients of attogeneic HSCT 
most had developed active GVHD (6/7 or 86%). 
ALL IMIs were caused by either Asper~illus (16/22 
or 73%) or Zy~omycetes (6/22 or 27%) species. 
Pneumonia was the predominant manifestation of 
IMIs (17/22), whereas there were 4 cases of dis- 
seminated infection and 1 case of sinusitis. 
The median day of FDG PET study in respect to IMI 
diagnosis was day 15 (range: day 26 to day 60). The 
median standardized uptake value SUV of Lesions 
caused by IMIs was 3.7 (range: 0.9-11.8). In 16 
eLigibLe patients, FDG PET revealed an occult site 
of infection in 3 (19%) cases of disseminated IMIs 
(incLuding 2 cases with CNS involvement) and was 
heLpfuL in guiding antifungat treatment in 9 (56%) 
patients with IMI. 
Conclusion: FDG PET imaging has the potential to 
become a useful toot for diagnosis of occult foci 
of disseminated IMIs and monitoring of antifungat 
treatment. However, prospective validation and 
analysis of cost effectiveness of FDG PET imaging 
in patients with IMIs is needed. 
Background: Invasive mold infections (IMIs) are 
Leading causes of mortality in severely immuno- 
